DMF filings hit all-time high in Q3 2024; China tops list with 58% increase in Type II submissions

Data Compilation
#PharmaFlow

Pipeline Prospector Sept 2024: BMS wins landmark FDA approval for schizophrenia med; Sanofi’s Dupixent okayed for COPD

Stock Recap
#PipelineProspector

Metoclopramide HCl

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

21 API Suppliers, 10 USDMF, 4 CEP/COS, 1 JDMF, 3 EU WC, 9 NDC API, 15 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

INTERMEDIATES

2 API Suppliers

2 API Suppliers

FINISHED DOSAGE FORMULATIONS

115 FDF Dossiers, 77 FDA Orange Book, 8 Europe, 8 Canada, 4 South Africa, 18 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - EQ 5MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, ORALLY DISINTEGRATING;ORAL - EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, ORALLY DISINTEGRATING;ORAL - EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Evonik, 5 Rochem International Inc, 17 SPI Pharma, 6 DKSH, 5 Boai NKY Pharmaceuticals Ltd, 14 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 ACG Worldwide, 6 Actylis, 1 Alcedo Pharmachem, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 17 BASF, 2 Corel Pharma Chem, 6 DFE Pharma, 1 Finar, 7 Gangwal Chemicals, 1 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 27 Kerry, 3 Lonza Capsugel, 16 Microlex e.U, 2 Novo Excipients, 4 Pharmatrans-Sanaq, 6 Pluviaendo, 3 Prachin Chemical, 1 Qualicaps, 28 Roquette, 1 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 2 Ulanqab Kema New Material, 2 Valens Pharmachem, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

90 Fillers, Diluents & Binders, 46 Direct Compression, 32 Disintegrants & Superdisintegrants, 24 Taste Masking, 23 Granulation, 23 Thickeners and Stabilizers, 18 Chewable & Orodispersible Aids, 18 Co-Processed Excipients, 16 Film Formers & Plasticizers, 16 Parenteral, 15 Lubricants & Glidants, 11 Solubilizers, 10 Controlled & Modified Release, 10 Coating Systems & Additives, 8 Empty Capsules, 5 Topical, 4 Emulsifying Agents, 2 API Stability Enhancers, 1 Soft Gelatin, 1 Rheology Modifiers

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 2 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

8 Finished Drug Prices

8 Finished Drug Prices

MARKET PLACE

10 APIs, 1 FDF Dossiers

PATENTS & EXCLUSIVITIES

4 US Patents

4 US Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 1 USP, 1 Others

$ Xls download

Filters

Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	MF Registration No.	Classification	Initial Date of Reg.	Latest Date of Reg.	Registrant's Address
26/09/2024	Amsa Spa	Italy	AMSA S. p. A.	221MF10057	METOCLOPRAMIDE DIHYDROCHLORIDE	2009-03-19	2020-04-02	VIALE DEL GHISALLO, 20 20151 MILAN ITALY

Metoclopramide HCl

Metoclopramide HCl

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

21 API Suppliers

10 USDMF

4 CEP/COS

1 JDMF

3 EU WC

9 NDC API

15 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

3 Drugs in Development

INTERMEDIATES

2 API Suppliers

FINISHED DOSAGE FORMULATIONS

115 FDF Dossiers

77 FDA Orange Book

8 Europe

8 Canada

4 South Africa

18 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - EQ 5MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, ORALLY DISINTEGRATING;ORAL - EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, ORALLY DISINTEGRATING;ORAL - EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Evonik

5 Rochem International Inc

17 SPI Pharma

6 DKSH

5 Boai NKY Pharmaceuticals Ltd

14 Gangwal Healthcare

3 Nanjing Well Pharmaceutical

1 Pfanstiehl

4 ACG Worldwide

6 Actylis

1 Alcedo Pharmachem

7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

17 BASF

2 Corel Pharma Chem

6 DFE Pharma

1 Finar

7 Gangwal Chemicals

1 Ideal Cures Pvt Ltd

4 Ingredion Pharma Solutions

27 Kerry

3 Lonza Capsugel

16 Microlex e.U

2 Novo Excipients

4 Pharmatrans-Sanaq

6 Pluviaendo

3 Prachin Chemical

1 Qualicaps

28 Roquette

1 Seppic

4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

2 Shijiazhuang Huaxu Pharmaceutical

10 Sigachi Industries

2 Ulanqab Kema New Material

2 Valens Pharmachem

3 Vasa Pharmachem

1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

90 Fillers, Diluents & Binders

46 Direct Compression

32 Disintegrants & Superdisintegrants

24 Taste Masking

23 Granulation

23 Thickeners and Stabilizers

18 Chewable & Orodispersible Aids

18 Co-Processed Excipients

16 Film Formers & Plasticizers

16 Parenteral

15 Lubricants & Glidants

11 Solubilizers

INJECTABLE;INJECTION - EQ 5MG BASE/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, ORALLY DISINTEGRATING;ORAL - EQ 10MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, ORALLY DISINTEGRATING;ORAL - EQ 5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons